Charles River Laboratories International (CRL) Competitors $143.49 +2.11 (+1.49%) As of 05/20/2025 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CRL vs. MTD, WAT, ILMN, TECH, BIO, BRKR, PACB, HBIO, TMO, and AShould you be buying Charles River Laboratories International stock or one of its competitors? The main competitors of Charles River Laboratories International include Mettler-Toledo International (MTD), Waters (WAT), Illumina (ILMN), Bio-Techne (TECH), Bio-Rad Laboratories (BIO), Bruker (BRKR), Pacific Biosciences of California (PACB), Harvard Bioscience (HBIO), Thermo Fisher Scientific (TMO), and Agilent Technologies (A). These companies are all part of the "life sciences tools & services" industry. Charles River Laboratories International vs. Mettler-Toledo International Waters Illumina Bio-Techne Bio-Rad Laboratories Bruker Pacific Biosciences of California Harvard Bioscience Thermo Fisher Scientific Agilent Technologies Charles River Laboratories International (NYSE:CRL) and Mettler-Toledo International (NYSE:MTD) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, institutional ownership, valuation, community ranking, earnings, dividends, media sentiment, risk and analyst recommendations. Which has more volatility and risk, CRL or MTD? Charles River Laboratories International has a beta of 1.5, indicating that its share price is 50% more volatile than the S&P 500. Comparatively, Mettler-Toledo International has a beta of 1.4, indicating that its share price is 40% more volatile than the S&P 500. Does the media prefer CRL or MTD? In the previous week, Charles River Laboratories International had 1 more articles in the media than Mettler-Toledo International. MarketBeat recorded 24 mentions for Charles River Laboratories International and 23 mentions for Mettler-Toledo International. Mettler-Toledo International's average media sentiment score of 1.42 beat Charles River Laboratories International's score of 1.22 indicating that Mettler-Toledo International is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Charles River Laboratories International 19 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Mettler-Toledo International 18 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is CRL or MTD more profitable? Mettler-Toledo International has a net margin of 22.29% compared to Charles River Laboratories International's net margin of 0.52%. Charles River Laboratories International's return on equity of 14.69% beat Mettler-Toledo International's return on equity.Company Net Margins Return on Equity Return on Assets Charles River Laboratories International0.52% 14.69% 6.79% Mettler-Toledo International 22.29%-591.54%26.78% Which has stronger earnings & valuation, CRL or MTD? Mettler-Toledo International has lower revenue, but higher earnings than Charles River Laboratories International. Charles River Laboratories International is trading at a lower price-to-earnings ratio than Mettler-Toledo International, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCharles River Laboratories International$4.02B1.75$474.62M-$0.65-220.75Mettler-Toledo International$3.83B6.43$863.14M$40.1029.56 Do analysts rate CRL or MTD? Charles River Laboratories International presently has a consensus price target of $172.31, suggesting a potential upside of 20.08%. Mettler-Toledo International has a consensus price target of $1,302.11, suggesting a potential upside of 9.84%. Given Charles River Laboratories International's higher possible upside, equities research analysts clearly believe Charles River Laboratories International is more favorable than Mettler-Toledo International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Charles River Laboratories International 1 Sell rating(s) 13 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.12Mettler-Toledo International 0 Sell rating(s) 6 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.40 Do insiders & institutionals have more ownership in CRL or MTD? 98.9% of Charles River Laboratories International shares are owned by institutional investors. Comparatively, 95.1% of Mettler-Toledo International shares are owned by institutional investors. 1.3% of Charles River Laboratories International shares are owned by insiders. Comparatively, 0.8% of Mettler-Toledo International shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the MarketBeat Community prefer CRL or MTD? Charles River Laboratories International received 123 more outperform votes than Mettler-Toledo International when rated by MarketBeat users. Likewise, 59.47% of users gave Charles River Laboratories International an outperform vote while only 56.26% of users gave Mettler-Toledo International an outperform vote. CompanyUnderperformOutperformCharles River Laboratories InternationalOutperform Votes49659.47% Underperform Votes33840.53% Mettler-Toledo InternationalOutperform Votes37356.26% Underperform Votes29043.74% SummaryCharles River Laboratories International beats Mettler-Toledo International on 10 of the 18 factors compared between the two stocks. Get Charles River Laboratories International News Delivered to You Automatically Sign up to receive the latest news and ratings for CRL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRL vs. The Competition Export to ExcelMetricCharles River Laboratories InternationalCommercial physical research IndustryMedical SectorNYSE ExchangeMarket Cap$7.05B$2.98B$5.43B$19.70BDividend YieldN/A2.27%5.22%3.84%P/E Ratio956.60105.7626.8335.13Price / Sales1.75164.75393.9834.12Price / Cash7.4834.5738.2517.51Price / Book2.122.426.874.78Net Income$474.62M$113.28M$3.22B$1.02B7 Day Performance3.08%1.77%6.76%1.62%1 Month Performance39.72%2.52%13.66%13.00%1 Year Performance-35.21%-8.44%18.27%5.59% Charles River Laboratories International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRLCharles River Laboratories International4.7438 of 5 stars$143.49+1.5%$172.31+20.1%-35.7%$7.05B$4.02B956.6021,400Positive NewsMTDMettler-Toledo International4.1073 of 5 stars$1,175.33+8.7%$1,296.13+10.3%-21.9%$24.43B$3.83B29.0018,000Positive NewsAnalyst UpgradeWATWaters3.4286 of 5 stars$366.80+6.6%$390.19+6.4%+2.3%$21.83B$2.98B34.258,200Trending NewsILMNIllumina4.8208 of 5 stars$81.57+7.7%$130.95+60.5%-22.4%$12.91B$4.37B-10.6211,500Positive NewsAnalyst ForecastTECHBio-Techne4.8686 of 5 stars$53.90+7.9%$73.44+36.3%-40.0%$8.52B$1.21B54.443,000Positive NewsDividend AnnouncementHigh Trading VolumeBIOBio-Rad Laboratories4.7151 of 5 stars$254.32+6.6%$327.40+28.7%-15.5%$7.12B$2.54B-3.918,200Positive NewsBRKRBruker4.9365 of 5 stars$40.26+7.3%$60.10+49.3%-50.1%$6.10B$3.45B52.978,520Dividend AnnouncementGap UpHigh Trading VolumePACBPacific Biosciences of California1.6417 of 5 stars$1.10-1.8%$2.50+127.3%-46.9%$330.05M$152.36M-0.67730Gap UpHBIOHarvard Bioscience3.8697 of 5 stars$0.35+11.8%$4.50+1,178.0%-89.7%$15.57M$94.14M-1.07490High Trading VolumeTMOThermo Fisher Scientific4.9962 of 5 stars$432.16+7.2%$607.43+40.6%-30.4%$163.14B$42.90B26.14130,000Positive NewsAnalyst RevisionAAgilent Technologies4.876 of 5 stars$115.53+8.0%$143.00+23.8%-26.7%$32.94B$6.51B26.5617,900News CoveragePositive NewsUpcoming Earnings Related Companies and Tools Related Companies Mettler-Toledo International Alternatives Waters Alternatives Illumina Alternatives Bio-Techne Alternatives Bio-Rad Laboratories Alternatives Bruker Alternatives Pacific Biosciences of California Alternatives Harvard Bioscience Alternatives Thermo Fisher Scientific Alternatives Agilent Technologies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CRL) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Charles River Laboratories International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CRL Stock Free CRL Stock Alerts